Zobrazeno 1 - 10
of 139
pro vyhledávání: '"Cinzia, Azzoni"'
Autor:
Francesca Negri, Lorena Bottarelli, Giuseppe Pedrazzi, Michele Maddalo, Ludovica Leo, Gianluca Milanese, Roberto Sala, Michele Lecchini, Nicoletta Campanini, Cecilia Bozzetti, Andrea Zavani, Gianluca Di Rienzo, Cinzia Azzoni, Enrico Maria Silini, Nicola Sverzellati, Federica Gaiani, Gian Luigi de’ Angelis, Letizia Gnetti
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionThe Notch intracellular domain (NICD) and its ligands Jagged-1(Jag1), Delta-like ligand (DLL-3) and DLL4 play an important role in neoangiogenesis. Previous studies suggest a correlation between the tissue levels of NICD and response to t
Externí odkaz:
https://doaj.org/article/7b444c4b7221495b890416abc0bc4077
Autor:
Roberta Minari, PhD, Samuel Valentini, MSc, Denise Madeddu, PhD, Andrea Cavazzoni, PhD, Silvia La Monica, PhD, Costanza Anna Maria Lagrasta, MSc, Roberto Bertorelli, MSc, Veronica De Sanctis, PhD, Paola Fassan, MSc, Cinzia Azzoni, PhD, Lorena Bottarelli, PhD, Caterina Frati, PhD, Letizia Gnetti, MD, Francesco Facchinetti, MD, Pier Giorgio Petronini, PhD, Roberta Alfieri, PhD, Alessandro Romanel, PhD, Marcello Tiseo, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 2, Pp 100278- (2022)
Introduction: ALK tyrosine kinase inhibitors (TKIs) are the standard treatment for advanced ALK-positive NSCLC. Nevertheless, drug resistance inevitably occurs. Here, we report a case of a patient with metastatic ALK-positive lung adenocarcinoma with
Externí odkaz:
https://doaj.org/article/e7a0f0aaa4584907a17791252608959c
Autor:
Giulia Mazzaschi, Fabiana Perrone, Roberta Minari, Michela Verzè, Cinzia Azzoni, Lorena Bottarelli, Monica Pluchino, Maria Pia Armillotta, Annalisa Ubaldi, Annalisa Altimari, Elisa Gruppioni, Francesca Sperandi, Elisa Andrini, Giorgia Guaitoli, Stefania Bettelli, Lucia Longo, Federica Bertolini, Fausto Barbieri, Maria Pagano, Candida Bonelli, Elena Tagliavini, Davide Nicoli, Alessandro Ubiali, Adriano Zangrandi, Serena Trubini, Manuela Proietto, Letizia Gnetti, Marcello Tiseo
Publikováno v:
Clinical Lung Cancer. 23:e478-e488
Targeting Kirsten Rat Sarcoma (KRAS) has been deemed impossible for long time, but new drugs have recently demonstrated promising results. Evidence on the outcome of KRAS-mutant advanced-NSCLC treated with new standard regimens are still scarce. Thus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7053999a8fa97bfc0f7fa4b0494b6c82
https://doi.org/10.1016/j.cllc.2022.07.005
https://doi.org/10.1016/j.cllc.2022.07.005
Autor:
Fabiana Perrone, Giulia Mazzaschi, Roberta Minari, Michela Verzè, Cinzia Azzoni, Lorena Bottarelli, Rita Nizzoli, Monica Pluchino, Annalisa Altimari, Elisa Gruppioni, Francesca Sperandi, Elisa Andrini, Giorgia Guaitoli, Federica Bertolini, Fausto Barbieri, Stefania Bettelli, Lucia Longo, Maria Pagano, Candida Bonelli, Elena Tagliavini, Davide Nicoli, Alessandro Ubiali, Adriano Zangrandi, Serena Trubini, Manuela Proietto, Letizia Gnetti, Marcello Tiseo
Publikováno v:
Cancers; Volume 14; Issue 8; Pages: 2019
Introduction: BRAF mutation involved 2–4% of lung adenocarcinoma. Differences in clinicopathologic features and patient outcome exist between V600E and non-V600E BRAF mutated NSCLC. Thus, we sought to assess the frequency and clinical relevance of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53b1c1e8917f636ad5da3248d3650b3f
Autor:
Agnese Cosenza, Cinzia Azzoni, Giuseppe Caruso, Costanza Lagrasta, Roberta Minari, Paola Bordi, Enrico Maria Silini, Leonarda Ferri, Letizia Gnetti, Marcello Tiseo, Lorena Bottarelli, Anna Squadrilli
Publikováno v:
Transl Lung Cancer Res
Anaplastic lymphoma kinase tyrosine kinase inhibitors (ALK-TKIs) are the standard treatment for advanced ALK-positive non-small cell lung cancer (NSCLC) allowing survivals up to 5 years. However, duration of responses is limited by the almost certain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::599cb01b08209b1c32e51a823da3ec95
https://doi.org/10.21037/tlcr.2020.04.03
https://doi.org/10.21037/tlcr.2020.04.03
Autor:
Maria Majori, Donatello Gasparro, Rita Nizzoli, Gabriella Becchi, Cinzia Azzoni, Nicoletta Campanini, Marcello Tiseo, Letizia Gnetti, Massimo De Filippo, Costanza Lagrasta, Andrea Zavani, Cecilia Bozzetti, Enrico Maria Silini, Giuseppe Pedrazzi, Anna Squadrilli
Publikováno v:
Immunotherapy. 12:183-193
Aim: Programmed cell death-ligand 1 (PD-L1) predicts response to immune checkpoint inhibitors in non-small-cell lung cancer (NSCLC) patients. Most NSCLCs are diagnosed at an advanced stage and using minimally invasive diagnostic procedures that yield
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1993a08aec35ee1a8e707d38b394b1d8
https://doi.org/10.2217/imt-2019-0138
https://doi.org/10.2217/imt-2019-0138
Autor:
Roberta Minari, Samuel Valentini, Denise Madeddu, Andrea Cavazzoni, Silvia La Monica, Costanza Anna Maria Lagrasta, Roberto Bertorelli, Veronica De Sanctis, Paola Fassan, Cinzia Azzoni, Lorena Bottarelli, Caterina Frati, Letizia Gnetti, Francesco Facchinetti, Pier Giorgio Petronini, Roberta Alfieri, Alessandro Romanel, Marcello Tiseo
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 2, Pp 100278-(2022)
Introduction: ALK tyrosine kinase inhibitors (TKIs) are the standard treatment for advanced ALK-positive NSCLC. Nevertheless, drug resistance inevitably occurs. Here, we report a case of a patient with metastatic ALK-positive lung adenocarcinoma with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::beaf176c0597ec4b5c80b350c3ee274f
http://hdl.handle.net/11572/338238
http://hdl.handle.net/11572/338238
Autor:
Cecilia Bozzetti, Federico Quaini, Anna Squadrilli, Marcello Tiseo, Caterina Frati, Costanza Lagrasta, Cinzia Azzoni, Lorena Bottarelli, Maricla Galetti, Angela Alama, Silvana Belletti, Rita Gatti, Antonio Passaro, Angela Gradilone, Andrea Cavazzoni, Roberta Alfieri, Pier Giorgio Petronini, Mara Bonelli, Angela Falco, Cecilia Carubbi, Giuseppe Pedrazzi, Rita Nizzoli, Nadia Naldi, Carmine Pinto, Andrea Ardizzoni
Publikováno v:
PLoS ONE, Vol 10, Iss 11, p e0142891 (2015)
The exclusion of circulating tumor cells (CTCs) that have lost epithelial antigens during the epithelial-to-mesenchymal transition (EMT) process by using Epithelial Cell Adhesion Molecule (EpCAM) based capture methods is still a matter of debate. In
Externí odkaz:
https://doaj.org/article/ac6c68e544fd48c89be7b39454f37767
Autor:
Maria Michiara, Enrico Maria Silini, Annalisa Gilli, Guido Rindi, Stefano Cascinu, Matteo Goldoni, Cinzia Azzoni, Letizia Gnetti, Annamaria Giorgi, Laura Manotti, Francesco Leonardi, Lorena Bottarelli, Francesca Negri, P. Sgargi
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-9 (2019)
Scientific Reports
Scientific Reports
Recent data suggest that tumor laterality and mucinous histology may be clinically relevant. We investigated how both variables impact on the prognosis and the response to therapies in a large population-based cohort of cancer patients. Incidence dat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e39b9f57fb6ed288863fff8dbb77f9d8
http://link.springer.com/article/10.1038/s41598-019-40096-6
http://link.springer.com/article/10.1038/s41598-019-40096-6
Autor:
Kaifeng Liu, Annalisa Capobianco, Emma Assi, Mayuko Uehara, B. Nelson Chau, Anna Solini, Paolo Fiorina, Massimo Venturini, Enrico Ammirati, Lorena Bottarelli, Gabriella Becchi, Luciano Potena, Cinzia Azzoni, Maria Frigerio, Anna Maestroni, Moufida Ben Nasr, Francesca D'Addio, Vera Usuelli, Andy Joe Seelam, M. Sabatino, Ida Pastore, Marcus G. Pezzolesi, Chiara Rossi, Albert K. Tai, Gian Vincenzo Zuccotti, Elena Rigamonti, Jun Yang, Reza Abdi, Domenico Corradi, Basset El Essawy, Eduardo Castillo-Leon, Cristian Loretelli, Gary A. Visner, Andrea Vergani
Publikováno v:
American Journal of Transplantation
Despite much progress in improving graft outcome during cardiac transplantation, chronic allograft vasculopathy (CAV) remains an impediment to long‐term graft survival. MicroRNAs (miRNAs) emerged as regulators of the immune response. Here, we aimed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3ca24dcbbe6f1f6a1930b671dc90ef8
http://hdl.handle.net/11383/2114076
http://hdl.handle.net/11383/2114076